MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria

NCT03097250 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-10-19

No results posted yet for this study

Summary

This is a study about the relationship of brain biomarkers with neuropsychological functioning in PKU. All participants will undergo MRI spectroscopy, will provide a blood specimen and will receive neuropsychological testing.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Susan E Waisbren, PhD · Boston Children's Hospital

Eligibility

Min Age
12 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-25
Primary Completion
2018-07-01
Completion
2018-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03097250 on ClinicalTrials.gov